Molina Healthcare Gains as Investors Reassess Raised 2026 Earnings Outlook

Molina Healthcare (MOH) is up 5.9% today. Here is some analysis on what might have caused this price movement.

Analysis: The move appears tied to a rebound in sentiment after investors digested Molina’s late-July earnings report, which included a higher 2026 adjusted earnings outlook despite ongoing revenue and cost pressures. There does not appear to be a major new company-specific filing or press release today, so this could be because traders are rotating back into a stock that sold off sharply after earnings and may now be viewed as oversold.

Details:

Molina’s second-quarter 2026 results showed adjusted diluted earnings per share of $1.51, and management lifted full-year adjusted earnings guidance to at least $5.25 per share from at least $5.00.

The same earnings update also pointed to pressure from higher medical costs and a weaker full-year revenue outlook, which had triggered a sharp post-earnings decline in the shares late last month.

Molina’s most recent listed current report on its investor relations SEC filings page was dated July 22, 2026, suggesting there was no obvious fresh corporate catalyst released today.

Management has also described 2026 as a challenging margin year, so any signs that profitability may hold up better than feared can support a bounce in the stock.

Sources:

Molina Healthcare, SEC, Becker's

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$MOH Insider Trading Activity

$MOH insiders have traded $MOH stock on the open market 4 times in the past 6 months. Of those trades, 1 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $MOH stock by insiders over the last 6 months:

JEFF D. BARLOW (Chief Legal Officer) sold 17,811 shares for an estimated $3,314,983
MAURICE HEBERT (Chief Accounting Officer) sold 600 shares for an estimated $114,930
RICHARD C ZORETIC purchased 800 shares for an estimated $100,128
RONNA ROMNEY sold 506 shares for an estimated $74,341

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$MOH Hedge Fund Activity

We have seen 352 institutional investors add shares of $MOH stock to their portfolio, and 307 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

LINGOTTO INVESTMENT MANAGEMENT LLP added 2,511,490 shares (+inf%) to their portfolio in Q2 2026, for an estimated $574,377,763
AQR CAPITAL MANAGEMENT LLC added 2,452,990 shares (+597.7%) to their portfolio in Q1 2026, for an estimated $328,026,087
HARRIS ASSOCIATES L P removed 1,368,290 shares (-58.3%) from their portfolio in Q1 2026, for an estimated $182,974,580
JANE STREET GROUP, LLC added 712,027 shares (+591.0%) to their portfolio in Q1 2026, for an estimated $95,215,810
MAVERICK CAPITAL LTD added 645,768 shares (+inf%) to their portfolio in Q1 2026, for an estimated $86,355,325
CAPITAL WORLD INVESTORS removed 636,433 shares (-19.9%) from their portfolio in Q2 2026, for an estimated $145,552,227
VICTORY CAPITAL MANAGEMENT INC added 570,011 shares (+40.4%) to their portfolio in Q2 2026, for an estimated $130,361,515

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$MOH Price Targets

Multiple analysts have issued price targets for $MOH recently. We have seen 10 analysts offer price targets for $MOH in the last 6 months, with a median target of $187.5.

Here are some recent targets:

Andrew Mok from Barclays set a target price of $184.0 on 07/09/2026
Ben Hendrix from RBC Capital set a target price of $248.0 on 07/09/2026
John Stansel from JP Morgan set a target price of $191.0 on 06/08/2026
Erin Wright from Morgan Stanley set a target price of $167.0 on 06/04/2026
A.J. Rice from UBS set a target price of $202.0 on 05/22/2026
Michael Ha from Baird set a target price of $163.0 on 05/11/2026
Sarah James from Cantor Fitzgerald set a target price of $209.0 on 05/11/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.